United States · FDA National Drug Code directory
Ziprasidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0904-6270_a7d74c6c-aacf-42bf-8b75-4acce832eb94
- Product NDC
- 0904-6270
- Form
- CAPSULE
- Composition / generic term
- Ziprasidone
- Labeler
- Major Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120315
- Source listing expiry
- 20271231
Source-listed ingredients
- ZIPRASIDONE HYDROCHLORIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 40 BLISTER PACK in 1 CARTON (0904-6270-08) / 1 CAPSULE in 1 BLISTER PACK · 0904-6270-08
- 80 BLISTER PACK in 1 CARTON (0904-6270-45) / 1 CAPSULE in 1 BLISTER PACK · 0904-6270-45
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →